These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG). Pandey A; McGuire DK; de Lemos JA; Das SR; Berry JD; Brilakis ES; Banerjee S; Marso SP; Barsness GW; Simon DN; Roe M; Goyal A; Kosiborod M; Amsterdam EA; Kumbhani DJ Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):197-205. PubMed ID: 27166210 [TBL] [Abstract][Full Text] [Related]
3. Real-life characteristics and outcomes of patients who undergo percutaneous coronary intervention versus coronary artery bypass grafting for left main coronary artery disease: data from the prospective Multi-vessel Coronary Artery Disease (MULTICAD) Israeli Registry. Ram E; Goldenberg I; Kassif Y; Segev A; Lavee J; Einhorn-Cohen M; Raanani E Eur J Cardiothorac Surg; 2018 Oct; 54(4):717-723. PubMed ID: 29554237 [TBL] [Abstract][Full Text] [Related]
4. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data. Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199 [TBL] [Abstract][Full Text] [Related]
5. Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry. Lowenstern A; Wu J; Bradley SM; Fanaroff AC; Tcheng JE; Wang TY Am Heart J; 2019 Sep; 215():167-177. PubMed ID: 31349108 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2). Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R; Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550 [TBL] [Abstract][Full Text] [Related]
7. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936 [TBL] [Abstract][Full Text] [Related]
8. The Clinical SYNTAX score predicts survival better than the SYNTAX score in coronary revascularization. Barac YD; Witberg G; Assali A; Klempfner R; Krutzwald-Josefson E; Rubchevsky V; Abergel E; Kornowski R; Aravot D J Thorac Cardiovasc Surg; 2024 Jan; 167(1):164-173.e4. PubMed ID: 35331554 [TBL] [Abstract][Full Text] [Related]
9. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease. Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974 [TBL] [Abstract][Full Text] [Related]
10. Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial. Burgess SN; Mussap CJ; French JK Clin Ther; 2013 Aug; 35(8):1069-75. PubMed ID: 23973040 [TBL] [Abstract][Full Text] [Related]
11. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease. Ashrith G; Lee VV; Elayda MA; Reul RM; Wilson JM Am J Cardiol; 2010 Aug; 106(3):348-53. PubMed ID: 20643244 [TBL] [Abstract][Full Text] [Related]
12. Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial. Kim LJ; King SB; Kent K; Brooks MM; Kip KE; Abbott JD; Jacobs AK; Rihal C; Hueb WA; Alderman E; Sing IR; Attubato MJ; Feit F; JACC Cardiovasc Interv; 2009 May; 2(5):384-92. PubMed ID: 19463459 [TBL] [Abstract][Full Text] [Related]
13. Comparison of patients with multivessel disease treated at centers with and without on-site cardiac surgery. Ram E; Goldenberg I; Kassif Y; Segev A; Lavee J; Shlomo N; Raanani E J Thorac Cardiovasc Surg; 2018 Mar; 155(3):865-873.e3. PubMed ID: 29452484 [TBL] [Abstract][Full Text] [Related]
14. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study. Srinivas VS; Brooks MM; Detre KM; King SB; Jacobs AK; Johnston J; Williams DO Circulation; 2002 Sep; 106(13):1627-33. PubMed ID: 12270854 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease. Chang M; Ahn JM; Lee CW; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ J Am Coll Cardiol; 2016 Jul; 68(1):29-36. PubMed ID: 27364047 [TBL] [Abstract][Full Text] [Related]
16. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry. Bair TL; Muhlestein JB; May HT; Meredith KG; Horne BD; Pearson RR; Li Q; Jensen KR; Anderson JL; Lappé DL Circulation; 2007 Sep; 116(11 Suppl):I226-31. PubMed ID: 17846308 [TBL] [Abstract][Full Text] [Related]
17. Improved long-term survival for diabetic patients with surgical versus interventional revascularization. Kurlansky P; Herbert M; Prince S; Mack MJ Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials. Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654 [TBL] [Abstract][Full Text] [Related]
19. Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease. Qintar M; Humphries KH; Park JE; Arnold SV; Tang Y; Jones P; Salisbury AC; Kureshi F; Farkouh ME; Fuster V; Cohen DJ; Spertus JA J Am Coll Cardiol; 2019 Oct; 74(16):2074-2084. PubMed ID: 31623766 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial. Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW; Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]